Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec:30:80-6.
doi: 10.1016/j.copbio.2014.06.006. Epub 2014 Jul 3.

Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development

Affiliations
Review

Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development

Kelley M Heffner et al. Curr Opin Biotechnol. 2014 Dec.

Abstract

Recent advancements in proteomics have enabled the generation of high-quality data sets useful for applications ranging from target and monoclonal antibody (mAB) discovery to bioprocess optimization. Comparative proteomics approaches have recently been used to identify novel disease targets in oncology and other disease conditions. Proteomics has also been applied as a new avenue for mAb discovery. Finally, CHO and Escherichia coli cells represent the dominant production hosts for biopharmaceutical development, yet the physiology of these cells types has yet to be fully established. Proteomics approaches can provide new insights into these cell types, aiding in recombinant protein production, cell growth regulation, and medium formulation. Optimization of sample preparations and protein database developments are enhancing the quantity and accuracy of proteomic results. In these ways, innovations in proteomics are enriching biotechnology and bioprocessing research across a wide spectrum of applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of an optimized proteomics experiment for mammalian cell culture protein quantification. Proteins are extracted and subjected to reduction, alkylation, filter aided sample preparation, and digestion. Digested peptides are labeled with iTRAQ reagents, fractionated by bRPLC, and injected into LC/MS/MS. The resultant peaks are analyzed by mapping to CHO genome databases. Differences in peak levels represent relative protein expression levels between cell lines. Identification and quantification of proteins aids bioprocess development efforts to increase protein yields or other applications.
Figure 2
Figure 2
An example output for identified proteins in CHO-K1 proteome (CHO Proteome Database; URL: http://chogenome.org/proteomeSearch.php). (a) The protein name and accession number is retrieved after searching with a name. There are 6163 proteins total in this database (as shown by entering ‘%%’ for searching all the database proteins). (b) After clicking on an accession number, detailed information about a particular protein can be seen, including identified peptide sequences.

References

    1. Peng X, Gong F, Zhao Y, Zhou L, Xie Y, Liao H, Lin H, Li Z, Tang M, Tong A: Comparative proteomic approach identifies Pkm2 and cofilin-1 as potential diagnostic, prognostic, and therapeutic targets for pulmonary adenocarcinoma. PLoS ONE 2011, 6 10.1371/journal.pone.0027309. - DOI - PMC - PubMed
    1. PosthumaDeBoer J, Piersma SR, Pham TV, van Egmond PW, Knol JC, Cleton-Jansen AM, van Geer MA, van Beusechem VW, Kaspers GJ, van Royen BJ et al.: Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. Br J Cancer 2013, 109:2142–2154. - PMC - PubMed
    1. Frei AP, Jeon OY, Kilcher S, Moest H, Henning LM, Jost C, Pluckthun A, Mercer J, Aebersold R, Carreira EM et al.: Direct identification of ligand–receptor interactions on living cells and tissues. Nat Biotechnol 2012, 10:997–1001. - PubMed
    1. Cheung WC, Beausoleil SA, Zhang X, Sato S, Schieferl SM, Wieler JS, Beaudet JG, Ramenani RK, Popova L, Comb MJ et al.: A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol 2012, 30:447–452. - PubMed
    1. Wine Y, Boutz DR, Lavinder JJ, Miklos AE, Hughes RA, Hoi KH, Jung ST, Horton AP, Murrin EM, Ellington AD et al.: Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. PNAS 2013, 110:2993–2998. - PMC - PubMed
    2. The authors describe a novel methodology to determine antibody composition of the polyclonal serum response by use of antigen-affinity chromatography coupled to tandem mass spectrometry. The protocol offers new insights into understanding the antibody immune response.

Publication types

LinkOut - more resources